🇺🇸 FDA
Pipeline program

PGS 2.0

JIAI E2017-15

Unknown gene_therapy active

Quick answer

PGS 2.0 for Recurrent Pregnancy Loss is a Unknown program (gene_therapy) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Recurrent Pregnancy Loss
Phase
Unknown
Modality
gene_therapy
Status
active

Clinical trials